Kalijev Jodid Sandoz

Potassium Iodide, the active ingredient in Kalijev Jodid Sandoz, is a thyroid hormone precursor presented as an oral preparation for oral use. It is employed to prevent radioactive iodine uptake in the thyroid and to correct iodine deficiency in the general population. It is commonly used in emergency preparedness and routine supplementation programs.

GNH USA supplies Kalijev Jodid Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Kalijev Jodid Sandoz (potassium iodide) acts within the iodine metabolism pathway to address specific clinical needs.

- Radioactive iodine exposure: blocks thyroid uptake of radioactive iodine, reducing radiation dose to the gland and protecting thyroid function. - Iodine deficiency: supplies stable iodine to support normal thyroid hormone synthesis, helping prevent goitre and hypothyroidism. - Pre‑surgical thyroid preparation: provides iodine saturation to minimize intra‑operative thyroid hormone release and reduce risk of thyroid storm.

Potassium iodide may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Taste alteration: mild metallic or salty taste in the mouth. - Gastrointestinal discomfort: nausea, abdominal cramps, or mild diarrhea. - Skin reactions: rash or itching at the site of contact. - Salivary gland swelling: temporary enlargement of the parotid glands.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Thyrotoxicosis: excessive thyroid hormone release in susceptible individuals. - Hypersensitivity pneumonitis: rare lung inflammation presenting with cough and shortness of breath.

When using potassium iodide, several precautions should be observed to ensure safety and effectiveness. - Pregnancy: use only if clearly needed, as excess iodine may affect fetal thyroid function. - Breastfeeding: consider potential iodine transfer to the infant; consult a healthcare professional. - Pre‑existing thyroid disease: assess risk of hyperthyroidism or hypothyroidism before administration. - Age considerations: pediatric dosing requires careful calculation; elderly patients may have altered renal clearance. - Drug interactions: review concomitant medications that affect iodine metabolism. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Potassium iodide can interact with certain medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Antithyroid drugs (e.g., propylthiouracil, methimazole): may counteract iodine saturation, reducing protective effect. - Radioactive iodine therapy: potassium iodide can markedly decrease therapeutic uptake, compromising treatment outcomes.

Moderate Interactions (Monitor Closely): - Lithium: may increase risk of thyroid dysfunction when combined with excess iodine. - Amiodarone: high iodine content may exacerbate thyroid hormone disturbances. - ACE inhibitors or diuretics: may affect renal excretion of iodide, requiring monitoring of iodine levels.